Correlation Between Vir Biotechnology and Adaptive Biotechnologies

Can any of the company-specific risk be diversified away by investing in both Vir Biotechnology and Adaptive Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vir Biotechnology and Adaptive Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vir Biotechnology and Adaptive Biotechnologies Corp, you can compare the effects of market volatilities on Vir Biotechnology and Adaptive Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vir Biotechnology with a short position of Adaptive Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vir Biotechnology and Adaptive Biotechnologies.

Diversification Opportunities for Vir Biotechnology and Adaptive Biotechnologies

0.36

Correlation Coefficient

Vir Biotechnology  Adaptive Biotechnologies

Weak diversification

The 3 months correlation between Vir and Adaptive is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Vir Biotechnology and Adaptive Biotechnologies Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptive Biotechnologies and Vir Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vir Biotechnology are associated (or correlated) with Adaptive Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptive Biotechnologies has no effect on the direction of Vir Biotechnology i.e., Vir Biotechnology and Adaptive Biotechnologies go up and down completely randomly.

Pair Corralation between Vir Biotechnology and Adaptive Biotechnologies

Considering the 90-day investment horizon Vir Biotechnology is expected to under-perform the Adaptive Biotechnologies. But the stock apears to be less risky and, when comparing its historical volatility, Vir Biotechnology is 1.21 times less risky than Adaptive Biotechnologies. The stock trades about -0.04 of its potential returns per unit of risk. The Adaptive Biotechnologies Corp is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  808.00  in Adaptive Biotechnologies Corp on September 26, 2024 and sell it today you would lose (169.00) from holding Adaptive Biotechnologies Corp or give up 20.92% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Vir Biotechnology  vs.  Adaptive Biotechnologies Corp

Vir Biotechnology

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Vir Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady forward indicators, Vir Biotechnology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Adaptive Biotechnologies

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Adaptive Biotechnologies Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Adaptive Biotechnologies unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vir Biotechnology and Adaptive Biotechnologies

The main advantage of trading using opposite Vir Biotechnology and Adaptive Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vir Biotechnology position performs unexpectedly, Adaptive Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptive Biotechnologies will offset losses from the drop in Adaptive Biotechnologies' long position.

The idea behind Vir Biotechnology and Adaptive Biotechnologies Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.